Video News December 30, 2021Biogen stock surges on report of potential acquisition by Samsung Group 0 0 Share
Video News December 30, 2021The $42B Samsung Biogen deal is too cheap, says Oppenheimer Health Care analyst Holz 0 0 Share
Video News December 30, 2021Piper Sandler analyst on reports that Samsung may be in talks to buy Biogen 0 0 Share
Video News December 30, 2021Biogen shares jump higher on report of potential Samsung acquisition 0 0 Share
Video News December 30, 2021U.S. stocks should be overweighted in 2022, says Ironsides' Barry Knapp 0 0 Share
Video News December 30, 2021Jobless claims reflect labor shortage, says Bleakley's Boockvar 0 0 Share
Video News December 30, 2021Fed has tough decisions to make in 2022, says former Dallas Fed president Richard Fisher 0 0 Share
Video News December 30, 2021The market will have to stand on its own in 2022, says Rockefeller Family Office CIO 0 0 Share
Video News December 30, 2021Why the stock market rallied as COVID-19 cases reached pandemic high 0 0 Share
